Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva's Benign Opioid Settlement Isn't in the Bag Yet - WSJ
California judge rules for Israeli Teva in major opioid lawsuit - The Jerusalem Post
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
Teva CEO Says He's Still Hoping For a Nationwide Opioid Settlement | Barron's
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York State - CNN
Where is Kåre Schultz? | Ctech
Teva CEO: Company would have gone bankrupt without layoffs - Business - Haaretz.com
BDS movement on Twitter: "Another reason to boycott Israeli pharmaceutical giant TEVA. 40 U.S. states have accused TEVA and other drug companies of fraud. News report: https://t.co/qvQIuFr2ml https://t.co/NVPJhPWD4m" / Twitter
Pharmaceutical Company Reaches Settlement With Oklahoma In Opioid Case : NPR
Hunter strikes settlement with Teva Pharmaceuticals
Teva reaches $150 million deal with Texas to settle opioid-related claims | The Times of Israel
Teva to Pay California $69 Million in Narcolepsy Drug Settlement | Ctech
Teva sees 25% of US EpiPen auto-injector market by end 2019 | The Times of Israel
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Breaks Out Amid Hopes of Global Opioid Settlement
Stocks making the biggest moves midday: Teva Pharmaceutical, Boeing, Uber & more
Teva rewards CEO Schultz with $4M equity pay bump after companywide cutbacks | Fierce Pharma
U.S. accuses Israel's Teva of fixing drug prices
Teva Pharma Production Specialist Post Vacancy 2019
Teva CEO: Tough year ahead, but we're hitting cost-cutting targets - Israel News - The Jerusalem Post